Mastrapasqua Asset Management Inc Catalent, Inc. Transaction History

Mastrapasqua Asset Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$41.39 - $81.0 $121,686 - $238,140	-2,940 Reduced 22.17%	10,323 $464,000
Q3 2022 Oct 27, 2022	BUY	$72.36 - $113.1 $7,959 - $12,441	110 Added 0.84%	13,263 $960,000
Q2 2022 Jul 26, 2022	SELL	$87.2 - $114.05 $58,424 - $76,413	-670 Reduced 4.85%	13,153 $1.41 Million
Q1 2022 Apr 21, 2022	SELL	$94.19 - $124.49 $124,330 - $164,326	-1,320 Reduced 8.72%	13,823 $1.53 Million
Q4 2021 Jan 21, 2022	BUY	$119.57 - $139.07 $85,492 - $99,435	715 Added 4.96%	15,143 $1.94 Million
Q3 2021 Nov 01, 2021	SELL	$109.17 - $142.35 $16,921 - $22,064	-155 Reduced 1.06%	14,428 $1.92 Million
Q2 2021 Aug 06, 2021	BUY	$100.34 - $115.69 $76,760 - $88,502	765 Added 5.54%	14,583 $1.58 Million
Q1 2021 May 03, 2021	BUY	$101.51 - $125.27 $186,778 - $230,496	1,840 Added 15.36%	13,818 $1.46 Million
Q4 2020 Feb 02, 2021	SELL	$85.88 - $105.36 $2,748 - $3,371	-32 Reduced 0.27%	11,978 $1.25 Million
Q3 2020 Nov 12, 2020	BUY	$72.74 - $92.5 $36,006 - $45,787	495 Added 4.3%	12,010 $1.03 Million
Q2 2020 Jul 29, 2020	BUY	$48.02 - $79.04 $552,950 - $910,145	11,515 New	11,515 $844,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Mastrapasqua Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Mastrapasqua Asset Management Inc with notifications on news.